ClinicalTrials.Veeva

Menu
P

Psych Atlanta | Marietta, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Viloxazine
SPN-812
MK-1942
ABBV-932
Centanafadine
MK-1942-006
PCN-101
Cariprazine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER)

Objectives of this study are to determine whether active VNS Therapy treatment is superior to a no stimulation control in producing a reduction in ba...

Enrolling
Treatment Resistant Depression
Device: Vagus Nerve Stimulation (VNS)
Locations recently updated

Generalized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately t...

Enrolling
Generalized Anxiety Disorder (GAD)
Drug: Antidepressant Therapy (ADT)
Drug: ABBV-932

Trial sponsors

AbbVie logo
Supernus Pharmaceuticals logo
LivaNova logo
Merck Sharp & Dohme (MSD) logo
Otsuka logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems